Stromal cell-derived factor-1

Drug Profile

Stromal cell-derived factor-1

Alternative Names: SDF-1

Latest Information Update: 05 Oct 2006

Price : $50

At a glance

  • Originator Ono Pharmaceutical; Wyeth
  • Class CXC chemokines
  • Mechanism of Action Angiogenesis inducing agents; CXCR4 receptor agonists; Leukocyte stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued HIV infections

Most Recent Events

  • 05 Oct 2006 Discontinued - Preclinical for HIV infections treatment in Japan (unspecified route)
  • 05 Oct 2006 Discontinued - Preclinical for HIV infections treatment in USA (unspecified route)
  • 29 Jan 2003 Genetics Institute is now called Wyeth
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top